Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Positive Anal Carcinoma”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT02280811
What this trial is testing

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Who this might be right for
Vaginal CancerCervical CancerAnal Cancer+2 more
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT02615860
What this trial is testing

Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive Patients

Who this might be right for
Anal Intraepithelial Neoplasia (AIN) in HIV-infected Patients
University Hospital, Essen 560
Testing effectiveness (Phase 2)Study completedNCT01807546
What this trial is testing

Oral Rigosertib for Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more
Traws Pharma, Inc. 64
Not applicableStudy completedNCT02287961
What this trial is testing

Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men

Who this might be right for
Hiv Infection
ANRS, Emerging Infectious Diseases 516
Not applicableEnded earlyNCT02503111
What this trial is testing

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men

Who this might be right for
Anal DysplasiaHuman PapillomavirusAnal Cancer
University Health Network, Toronto 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT04432597
What this trial is testing

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Who this might be right for
HPV Positive CancerVulvar, Vaginal, Penile, Rectal CancerAnal Cancer+2 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Looking for participantsNCT05686226
What this trial is testing

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Who this might be right for
Cervical CancerThroat CancerOropharynx Cancer+18 more
Christian Hinrichs 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03947775
What this trial is testing

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Who this might be right for
Anal Intraepithelial NeoplasiaAnal CancerHuman Papilloma Virus
University Health Network, Toronto 228
Early research (Phase 1)Active Not RecruitingNCT02379520
What this trial is testing

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more
Baylor College of Medicine 32
Testing effectiveness (Phase 2)Study completedNCT02858310
What this trial is testing

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Who this might be right for
Papillomavirus InfectionsCervical Intraepithelial NeoplasiaCarcinoma In Situ+2 more
National Cancer Institute (NCI) 219
Testing effectiveness (Phase 2)Study completedNCT01209325
What this trial is testing

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

Who this might be right for
Anal CancerNonneoplastic ConditionPenile Cancer+1 more
AIDS Malignancy Consortium 149
Early research (Phase 1)Study completedNCT02526316
What this trial is testing

Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers

Who this might be right for
HPV-induced Cancers
Oryx GmbH & Co. KG 11
Testing effectiveness (Phase 2)Looking for participantsNCT05639972
What this trial is testing

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Who this might be right for
HPV-Associated Cervical CarcinomaHPV-Related CarcinomaHPV-Related Malignancy+14 more
Christian Hinrichs 15
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Testing effectiveness (Phase 2)Study completedNCT03946358
What this trial is testing

Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckAnal Canal CancerCervical Cancer
Centre Hospitalier Universitaire de Besancon 47
Large-scale testing (Phase 3)Study completedNCT01164722
What this trial is testing

Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia

Who this might be right for
Anal CancerNeoplasm of Uncertain Malignant PotentialNonneoplastic Condition+1 more
AIDS Malignancy Consortium 120
Testing effectiveness (Phase 2)Study completedNCT00428285
What this trial is testing

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

Who this might be right for
Anus NeoplasmsHIV Infections
Centre hospitalier de l'Université de Montréal (CHUM) 20
Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06505551
What this trial is testing

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

Who this might be right for
HPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell Carcinoma+4 more
SCG Cell Therapy Pte. Ltd. 66
Not applicableUnknownNCT03357991
What this trial is testing

E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSM

Who this might be right for
HPV - Anogenital Human Papilloma Virus InfectionHSIL, High Grade Squamous Intraepithelial LesionsAnal Cancer+1 more
Hospital Universitari de Bellvitge 355